Zusammenfassung
Die Synthese eines Analogen des Deamino-oxytocins, in dem ein Schwefelatom der Disulfidbrücke durch eine Methylengruppe ersetzt ist (I,X = CH2,R=H), wird beschrieben. Die Verbindung hat oxytocinähnliche biologische Wirkungen.
ReferencesReferences
V. du Vigneaud, C. Ressler, J. M. Swan, C. W. Roberts, P. G. Katsoyannis, andS. Gordon, J. Am. chem. Soc.75, 4879 (1953).
H. Tuppy, Biochim. biophys. Acta11, 449 (1953).
R. A. Turner, J. G. Pierce, andV. du Vigneaud, J. biol. Chem.193, 359 (1951).
Z. Beránková andF. Šorm, Coll. Czech. chem. Comm.26, 2557 (1961).
See alsoK. Jošt, V. G. Debabov, H. Nesvadba, andJ. Rudinger, Coll. Czech. chem. Comm.29, 419 (1964).
R. R. Sealock andV. du Vigneaud, J. Pharmacol. exp. Therap.54, 433 (1935).
S. Gordon andV. du Vigneaud, Proc. Soc. exp. Biol. Med.84, 723 (1953).
Recently, however,C. T. O. Fong, L. Silver, andD. D. Louie (Biophys. biochem. Res. Comm.14, 302 (1964)) have reported that desulfurized arginine vasopressin shows appreciable rat pressor and avian depressor activities.
L. Audrain andH. Clauser, Biochim. biophys. Acta30, 191 (1958).
J. M. Gulland andS. S. Randall, Biochem. J.29, 378, 391 (1935).
H. B. van Dyke, B. F. Chow, R. O. Greep, andA. Rothen, J. Pharmacol. exp. Therap.74, 190 (1942).
D. Jarvis andV. du Vigneaud, Science143, 545 (1964).
For summary seeI. L. Schwartz, H. Rasmussen, L. M. Livingston, andJ. Marc-Aurele, inOxytocin, Vasopressin and their Structural Analogues, Proc. 2nd intern. pharmacol. Meeting (Pergamon Press, 1964), vol. 10, p. 125.
V. du Vigneaud, G. Winestock, V. V. S. Murti, D. B. Hope, andR. D. Kimbrough, J. biol. Chem.235, PC64 (1960).
D. B. Hope, V. V. S. Murti, andV. du Vigneaud, J. biol. Chem.237, 1563 (1962).
D. B. Hope andV. du Vigneaud, J. biol. Chem.237, 3146 (1962).
R. D. Kimbrough, W. D. Cash, L. A. Branda, W. Y. Chan, andV. du Vigneaud, J. biol. Chem.238, 1411 (1963).
K. Jošt, J. Rudinger, andF. Šorm, Coll. Czech. chem. Comm.26, 2496 (1961).
All amino acids (except for glycine) are of thel configuration. Standard abbreviations for amino acids and protecting groups are used; seePeptides, Proc. 5th European Peptide Symp., Oxford, 1962 (Pergamon Press, 1963), p. 261.
R. B. Woodward andR. A. Olofson, J. Am. chem. Soc.83, 1007 (1961).
R. B. Woodward, R. A. Olofson, andH. Mayer, J. Am. chem. Soc.83, 1010 (1961).
K. Bláha andJ. Rudinger, unpublished results.
D. H. Spackman, W. H. Stein, andS. Moore, Analyt. Chem.30, 1190 (1958).
P. Holton, Brit. J. Pharmacol.3, 328 (1948).
J. M. Coon, Arch. int. Pharmacodyn.62, 79 (1939).
W. H. Sawyer, Endocrinology63, 694 (1958).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rudinger, J., Jošt, K. A biologically active analogue of oxytocin not containing a disulfide group. Experientia 20, 570–571 (1964). https://doi.org/10.1007/BF02150299
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02150299